Concepedia

Charles Merideth

CM

Statistics

Publications

9

Citations

764

H-Index

9

Active since

1982

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (Sweden)

San Diego Biomedical Research Institute

Charles Merideth is an author at AstraZeneca (United States) specializing in psychiatry, medicine, and pharmacotherapy.

Top concepts

Publications per year

1982–2011

9

Publications

9

A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)

Susan L. McElroy, Richard H. Weisler, William Chang et al. · The Journal of Clinical Psychiatry · 2010 · 320 citations

A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder.

John P. Feighner, Charles Merideth, Gordon A. Hendrickson · PubMed · 1982 · 187 citations

, , +22

Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder

Charles Merideth, Andrew J. Cutler, Fahua She et al. · International Clinical Psychopharmacology · 2011 · 67 citations

A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression

John P. Feighner, William F. Boyer, Charles Merideth et al. · International Clinical Psychopharmacology · 1989 · 58 citations

Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia

Dawn I. Velligan, Ronald Brenner, Franco Sicuro et al. · Schizophrenia Research · 2011 · 36 citations

, , +10

1–5 of 9